Verification of the usefulness of soft Micro Pore Filter: S-MPF, a filtration membrane that separates novel rare cells, in the extraction of peripheral blood circulation tumor cells in lung cancer patients

UMIN ID: UMIN000046205

Registered date:27/11/2021

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Lung cancer
• Date of first enrollment: 2021/11/17
• Target sample size: 25
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): 15 ml of peripheral blood collection

Outcome(s)

• Primary Outcome: Frequency of detection of circulating tumor cells in the blood by S-MPF method
• Secondary Outcome: Relationship between blood circulating tumor cells and pathological factors

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: 85years-old
• Gender: Male and Female
• Exclude criteria: 1. Active malignant tumors (simultaneous malignant tumors and hesychastic malignancies with a disease-free period of less than 5 years). However, lesions equivalent to Carcinoma in situ (intraepithelial cancer) and intramucosal cancer, which are judged to be cured by topical treatment, are not included in active malignant tumors). 2. Patients with infections requiring systemic treatment, including HIV, HBV, and HCV infections. 3. Without the use of an antipyretic, there is a fever of 38 centi degree or more at axillary temperature within 24 hours before registration. 4. The company is subjected to continuous systemic administration (internal or intravenous) of steroids or other immunosuppressants. A case in which the attending physician judged it to be inappropriate to carry out this study

Related Information

• Primary Sponsor: Nara Medical University
• Source(s) of Monetary Support: None